AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNTA
  4. [144] Centessa Pharmaceuticals plc American SEC Filing

[144] Centessa Pharmaceuticals plc American SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Filing content is currently unavailable.

Source:

Stock CNTA logo
Centessa Pharmaceuticals Plc

NASDAQ:CNTA

CNTA Rankings

#1940 Ranked by Market Cap
N/A Ranked by Dividends

CNTA Latest News

Aug 12, 2025
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025
Jun 16, 2025
Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year
May 19, 2025
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
May 14, 2025
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025
Mar 24, 2025
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

CNTA Latest SEC Filings

Aug 15, 2025
[144] Centessa Pharmaceuticals plc American SEC Filing
Aug 12, 2025
[SCHEDULE 13G/A] Centessa Pharmaceuticals plc American SEC Filing
Aug 12, 2025
[10-Q] Centessa Pharmaceuticals plc American Quarterly Earnings Report
Aug 12, 2025
[8-K] Centessa Pharmaceuticals plc American Reports Material Event
Aug 1, 2025
[Form 4] Centessa Pharmaceuticals plc American Insider Trading Activity

CNTA Stock Data

2.30B
118.99M
0.49%
94.42%
2.75%
Biotechnology
Pharmaceutical Preparations
United Kingdom
ALTRINCHAM, CHESHIRE